| Clinical data | |
|---|---|
| Other names | NET; NETP; Ethyltryptamine |
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H16N2 |
| Molar mass | 188.274 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 87 to 88 °C (189 to 190 °F) |
| |
| (verify) | |
N-Ethyltryptamine (NET), also abbreviated as NETP, is a tryptamine that is structurally related to N-methyltryptamine (NMT) and the psychedelic drugs N,N-dimethyltryptamine (DMT) and N,N-diethyltryptamine (DET).1
Use and effects
Alexander Shulgin included NET as an entry in his book TiHKAL (Tryptamines I Have Known and Loved).1 However, he stated that it had been subjected only to modest human trials and that no active dose level had been identified.1
Pharmacology
Pharmacodynamics
| Target | Affinity (Ki, nM) |
|---|---|
| 5-HT1A | IA |
| 5-HT2A | 38 (EC50Tooltip half-maximal effective concentration) 99% (EmaxTooltip maximal efficacy) |
| SERT | 19a (EC50) |
| NETTooltip Norepinephrine transporter | 3,862a (EC50) |
| DATTooltip Dopamine transporter | 6,660a (EC50) |
| Notes: The smaller the value, the more avidly the drug interacts with the site. Footnotes: a = Neurotransmitter release. Sources: 2 | |
NET has been found to act as a potent serotonin 5-HT2A receptor full agonist and a selective serotonin releasing agent.2 It is inactive at the 5-HT1A receptor.2 The drug is also a serotonin receptor agonist in the rat uterus and stomach strip.34
Chemistry
Synthesis
The chemical synthesis of NET has been described.1
Analogues
Analogues of NET include N-methyltryptamine (NMT), dimethyltryptamine (DMT), methylethyltryptamine (MET), and diethyltryptamine (DET), among others.1
Society and culture
Legal status
Canada
NET is not a controlled substance in Canada as of 2025.5
References
References
- NET Entry in TIHKAL
- Blough BE, Landavazo A, Decker AM, Partilla JS, Baumann MH, Rothman RB (October 2014). "Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes". Psychopharmacology (Berl). 231 (21): 4135–4144. doi:10.1007/s00213-014-3557-7. PMC 4194234. PMID 24800892.
- Barlow RB, Khan I (March 1959). "Actions of some analogues of tryptamine on the isolated rat uterus and on the isolated rat fundus strip preparations". Br J Pharmacol Chemother. 14 (1): 99–107. doi:10.1111/j.1476-5381.1959.tb00934.x. PMC 1481812. PMID 13651585.
- Vane JR (March 1959). "The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation". Br J Pharmacol Chemother. 14 (1): 87–98. doi:10.1111/j.1476-5381.1959.tb00933.x. PMC 1481817. PMID 13651584.
- "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.